ARCHIVES

In Brief: Phil Amoruso Will Be The New NCI Executive Officer; DRCCA Board Okays CCN Extension

This article is from The Cancer Letter archive.

Vol. 07 No. 01 | January 2, 1981

Download PDF Visit The Full Archive

Related Articles

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

June 12, 1992

Page 2: The Debate Over Brigham’s Containment Bag Study

November 21, 2014

US, Italy Plan Greater Scientific Collaboration

May 16, 2003

Hopkins to Commit Own Money for Junior Faculty Research

May 2, 1986

Switch To NTP Holds Down Entry Of New Compounds; Obey Supports NCI On Need For More Positions

March 16, 1979

“Sloppy” Cancer Control Grant Applications Turned Down At Twice NIH Disapproval Rate

November 7, 1975